Radiomics
Radiomics is a computational methodology that extracts large numbers of quantitative features from medical images (CT, MRI, PET) using automated image analysis and machine learning to discover imaging biomarkers associated with disease phenotype, prognosis, and treatment response. Developed by Lambin, Gillies, and colleagues in 2012, radiomics aims to decode the biology underlying visible imaging patterns, enabling personalized medicine through image-based phenotyping. It has emerged as a powerful tool in oncology for tumor characterization, prognosis prediction, and therapy response assessment.
Source record
Citations copied verbatim from the method’s source record. No claim-level verification is inferred from them.
- Lambin, P., Rios-Velazquez, E., Leijenaar, R., et al. (2012). Radiomics: extracting more information from medical images using advanced feature analysis. Nature Reviews Clinical Oncology, 9(12), 676-684. · DOI 10.1016/j.ejca.2011.11.036
- Gillies, R. J., Kinahan, P. E., Hricak, H. (2016). Radiomics: images are data. Radiology, 278(2), 563-577. · URL
- Kumar, V., Gu, Y., Basu, S., et al. (2012). Radiomics: the process and the challenges. Magnetic Resonance Imaging, 30(9), 1234-1248. · DOI 10.1016/j.mri.2012.06.010
Curated claims
Claims persisted in the evidence ledger, each with its own assessment.
This view does not invent a claim assessment when the ledger has none.
Related methods
Generated from the method graph and shown as machine-suggested relations — no evidence claim is inferred.